← Eichor
Study identifier: NCT03039439 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Condition: Parathyroid Gland Adenoma · Parathyroid Gland Atypical Adenoma · Parathyroid Gland Carcinoma  ·  Sponsor: M.D. Anderson Cancer Center

PhaseN/A
Planned participants310
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profiling of tumors may help doctors avoid inconsistencies in diagnosis, unnecessary or incomplete surgery, surgical morbidity, psychological stress, and inadequate follow up.

This description comes directly from the study's public registry record.

Talk to the study team

Nancy D. Perrier  ·  713-792-6940  ·  nperrier@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

M D Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03039439